Deutsch English Français

Contact

EP1734952

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1734952

EP1734952 - PROTEIN KINASE C INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND OF TRANSPLANT REJECTION [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 25.11.2011 Database last updated on 25.09.2024
Most recent event Tooltip	25.11.2011	Application deemed to be withdrawn	published on 28.12.2011 [2011/52]
Applicant(s)	For:BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR Novartis AG Lichtstrasse 35 4056 Basel / CH
	For:AT Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT
	[N/P]
Former [2009/43]	For:BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR Novartis AG Lichtstrasse 35 4056 Basel / CH
	For:AT Novartis Pharma GmbH Brunner Strasse 59 1230 Wien / AT
Former [2006/52]	For:BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR Novartis AG Lichtstrasse 35 4056 Basel / CH
	For:AT NOVARTIS-PHARMA GMBH Brunner Strasse 59 1230 Vienna / AT
Inventor(s)	01 / WAGNER, Jürgen Nussbaumweg 24 CH-4103 Bottmingen / CH
	02 / SCHULER, Walter Kirchstr. 49 79639 Grenzach-Wyhlen / DE
	[2006/52]
Representative(s)	von Sprecher, Georg, et al Novartis AG Corporate Intellectual Property 4002 Basel / CH
	[N/P]
Former [2006/52]	von Sprecher, Georg, et al Novartis AG Corporate Intellectual Property 4002 Basel / CH
Application number, filing date	05737146.0	07.04.2005
	[2006/52]
	WO2005EP03663
Priority number, date	GB20040008066	08.04.2004 Original published format: GB 0408066
	GB20040014540	29.06.2004 Original published format: GB 0414540
	GB20040022068	05.10.2004 Original published format: GB 0422068
	[2006/52]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2005097108
	Date:	20.10.2005
	Language:	EN
	[2005/42]
	Type:	A1 Application with search report
	No.:	EP1734952
	Date:	27.12.2006
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 20.10.2005 takes the place of the publication of the European patent application.
	[2006/52]
Search report(s)	International search report - published on:	EP	20.10.2005
Classification	IPC:	A61K31/404, A61P11/06, A61P17/06, A61P19/02, A61P21/04, A61P37/06	[2006/52]
	CPC:	A61K31/404 (EP,US); A61P1/04 (EP); A61P1/16 (EP); A61P11/06 (EP); A61P17/06 (EP); A61P19/02 (EP); (+) A61P21/04 (EP); A61P25/00 (EP); A61P29/00 (EP); A61P31/14 (EP); A61P37/06 (EP); A61P43/00 (EP) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/52]
Extension states	AL	Not yet paid
	BA	Not yet paid
	HR	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	YU	Not yet paid
Title	German:	PROTEINKINASE-C-HEMMER ZUR BEHANDLUNG VON AUTOIMMUNERKRANKUNGEN UND TRANSPLANTAT-ABSTOSSUNG	[2006/52]
	English:	PROTEIN KINASE C INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND OF TRANSPLANT REJECTION	[2006/52]
	French:	INHIBITEURS DE PROTEINE KINASE C DESTINES AU TRAITEMENT DE MALADIES AUTO-IMMUNES ET DE REJETS DE TRANSPLANTATION	[2006/52]
Entry into regional phase	08.11.2006	National basic fee paid
	08.11.2006	Designation fee(s) paid
	08.11.2006	Examination fee paid
Examination procedure	30.01.2006	Request for preliminary examination filed International Preliminary Examining Authority: EP
	08.11.2006	Examination requested [2006/52]
	21.12.2006	Amendment by applicant (claims and/or description)
	21.12.2010	Despatch of a communication from the examining division (Time limit: M06)
	01.07.2011	Application deemed to be withdrawn, date of legal effect [2011/52]
	08.08.2011	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/52]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.12.2010
Fees paid	Renewal fee
	02.05.2007	Renewal fee patent year 03
	28.03.2008	Renewal fee patent year 04
	16.04.2009	Renewal fee patent year 05
	25.03.2010	Renewal fee patent year 06
	12.04.2011	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XDY]US5545636 (HEATH WILLIAM FRANCIS JR [US], et al) [XD] 1,2,6-8,11 * formulae I-IV; column 12, line 60, 62 * [Y] 1-11;
		[Y]WO03082859 (NOVARTIS AG [CH], et al) [Y] 1-11 * page 1 and 2; page 20 *;
		[Y]WO03104222 (JANSSEN PHARMACEUTICA NV [BE], et al) [Y] 1-11 * page 10, line 5 - page 12, line 22; page 27, line 2 - page 28, line 17; page 36, line 17-22 *;
		[Y]WO9811105 (ASTRA AB [SE], et al) [Y] 1-11 * page3, line 7 - page 4, line 20; page 14, line 20-25 *;
		[Y]EP0470490 (HOFFMANN LA ROCHE [CH]) [Y] 1-11 * page 3, line 1-33; page 6, line 52 - page 7, line 6 *;
		[Y] - BRADSHAW D ET AL, "THERAPEUTIC POTENTIAL OF PROTEIN KINASE C INHIBITORS", AGENTS AND ACTIONS, BIRKHAEUSER VERLAG, BASEL, CH, (1993), vol. 38, ISSN 0065-4299, pages 135 - 147, XP009034964 [Y] 1-11 * page 135-138; figure 2 * DOI: http://dx.doi.org/10.1007/BF02027225
		[Y] - NIXON J S ET AL, "Novel, potent and selctive inhibitors of protein kinase C show oral anti-inflammatory activity", DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, BIOSCIENCE EDIPRINT INC, (1991), vol. 17, no. 8, ISSN 0378-6501, pages 389 - 393, XP002111051 [Y] 1-11 * abstract *
		[A] - HARRIS W ET AL, "Recent developments in protein kinase C inhibitors", EXPERT OPINION ON THERAPEUTIC PATENTS 1997 UNITED KINGDOM, (1997), vol. 7, no. 1, ISSN 1354-3776, pages 63 - 68, XP002337325 [A] 1-11 * the whole document * DOI: http://dx.doi.org/10.1517/13543776.7.1.63

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p